
William Damsky MD
Dermatopathology
Assistant Professor of Dermatology and Pathology
Join to View Full Profile
428 Columbus AveNew Haven, CT 06519
Phone+1 203-503-3000
Fax+1 203-785-7637
Dr. Damsky is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Yale-New Haven Medical CenterResidency, Internal Medicine, 2013 - 2014
University of Vermont College of MedicineClass of 2013
Certifications & Licensure
FL State Medical License 2022 - Present
CT State Medical License 2017 - 2026
American Board of Dermatology Dermatology
American Board of Dermatology Dermatopathology
Clinical Trials
- Open-label Trial of Tofacitinib in Cutaneous Sarcoidosis and Granuloma Annulare Start of enrollment: 2019 Apr 11
- Janus Kinase Inhibition in Sarcoidosis Start of enrollment: 2023 Jun 01
Roles: Principal Investigator, Contact
- Janus Kinase Inhibition in Granuloma Annulare Start of enrollment: 2023 Oct 27
Roles: Sponsor-Investigator, Principal Investigator, Contact
Publications & Presentations
PubMed
- Dermal Hypersensitivity Reaction Masquerading as Cellulitis: An Underrecognized Diagnostic Pitfall in the Inpatient Setting.Kailyn Valido, Suyeon Hong, William Damsky, Caroline A Nelson
International Journal of Dermatology. 2026-05-01 - Patients with granuloma annulare treated with Jak inhibitors show Cutibacterium acnes expansion: A clue to the mechanism underlying acneiform eruptions seen with Jak i...Yiwei Wang, Elexis Hernandez, Muhammad H Junejo, William Damsky
The Journal of Investigative Dermatology. 2026-05-01 - Leveraging Interpretable AI for Deciphering Signature Histopathologic Patterns.Jeff R Gehlhausen, Sophia T Luyten, Jun Deng, Goran Micevic, Jeffrey M Cohen
Journal of Cutaneous Pathology. 2026-04-01
Press Mentions
Novel LDTs Advance Dermatological DiagnosticsFebruary 14th, 2025
TNF or JAK: Which Target Is Key to Success in Tough-to-Treat Skin Disease?November 11th, 2021
Dramatic Responses in Cutaneous Sarcoidosis with JAK InhibitorNovember 7th, 2021
Grant Support
- Delineation of the immunobiology of sarcoidosis and characterization of the effects of Janus kinase inhibitionYALE UNIVERSITY2021–2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









